Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 3 of 491 results
Sort by: relevance publication year

Optical imaging for breast cancer prescreening

JOURNAL ARTICLE published July 2015 in Breast Cancer: Targets and Therapy

Authors: Anuradha Godavarty | Suset Rodriguez | Young-Jin Jung | Stephanie Gonzalez

Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health Plan

JOURNAL ARTICLE published August 2023 in Breast Cancer: Targets and Therapy

Authors: Reina Haque | Lie Hong Chen | Nina Oestreicher | Deepa Lalla | Rowan T Chlebowski

MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification

JOURNAL ARTICLE published September 2023 in Breast Cancer: Targets and Therapy

Authors: Çağlar Ünal | Tolga Özmen | Ahmet Serkan İlgün | Çetin Ordu | Enver Özkurt | Naziye Ak | Gül Alço | Zeynep Erdoğan İyigün | Sevgi Kurt | Tomris Duymaz | Mehmet Alper Öztürk | Filiz Elbüken Çelebi | Kanay Yararbaş | Gürsel Soybir | Fatma Aktepe | Vahit Özmen

Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting

JOURNAL ARTICLE published March 2024 in Breast Cancer: Targets and Therapy

Authors: Sarah Sharman Moser | Lior Apter | Idit Livnat | Roni Ginsburg | Adva Yarden | Michal Drori | Anat Drizon | Gabriel Chodick | Nava Siegelmann-Danieli

Immunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancer

JOURNAL ARTICLE published December 2014 in Breast Cancer: Targets and Therapy

Authors: Jennifer Sims-Mourtada | Lynn Opdenaker | Kimberly Arnold | Ryan Pohlig | Daniel Flynn | Jayasree Padmanabhan

A Real-World Data Retrospective Cohort Study of Low Estrogen Receptor-Positive Early Breast Cancer: Natural History and Treatment Outcomes

JOURNAL ARTICLE published August 2022 in Breast Cancer: Targets and Therapy

Authors: Shahla Bari | David Boulware | Jiannong Li | Loretta Loftus | Aixa Soyano Muller | Zena Jameel | Hung Khong | Brian J Czerniecki | Ricardo LB Costa

<p>Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment</p>

JOURNAL ARTICLE published July 2019 in Breast Cancer: Targets and Therapy

Authors: Vladimir M Perelmuter | Liubov A Tashireva | Olga E Savelieva | Evgeny V Denisov | Evgeniya V Kaigorodova | Marina V Zavyalova | Nadezhda V Cherdyntseva

Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy

JOURNAL ARTICLE published December 2022 in Breast Cancer: Targets and Therapy

Authors: Yi-Zi Zheng | Jia-Ying Li | Lv-Wen Ning | Ni Xie

miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells

JOURNAL ARTICLE published August 2022 in Breast Cancer: Targets and Therapy

Authors: Dua Hammash | Mona Mahfood | Ghalia Khoder | Munazza Ahmed | Abdelaziz Tlili | Rifat Hamoudi | Rania Harati

The expanding role of pertuzumab in the treatment of HER2-positive breast cancer

JOURNAL ARTICLE published May 2015 in Breast Cancer: Targets and Therapy

Authors: Javier Cortes | Irene Moya-Horno

<p>Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration</p>

JOURNAL ARTICLE published February 2019 in Breast Cancer: Targets and Therapy

Authors: Eileen Tremmel | Simone Hofmann | Christina Kuhn | Helene Heidegger | Sabine Heublein | Kerstin Hermelink | Rachel Wuerstlein | Nadia Harbeck | Doris Mayr | Sven Mahner | Nina Ditsch | Udo Jeschke | Aurelia Vattai

Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancer

JOURNAL ARTICLE published October 2011 in Breast Cancer: Targets and Therapy

Authors: Bill Sikov

Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site

JOURNAL ARTICLE published August 2017 in Breast Cancer: Targets and Therapy

Authors: Elyse Lower | Shagufta Khan | Diane Kennedy | Robert Baughman

<p>Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives</p>

JOURNAL ARTICLE published March 2020 in Breast Cancer: Targets and Therapy

Authors: Monica Iorfida | Manuelita Mazza | Elisabetta Munzone

Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients

JOURNAL ARTICLE published November 2011 in Breast Cancer: Targets and Therapy

Authors: Winnie Yeo

<em>CYP2D6</em> polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study

JOURNAL ARTICLE published March 2017 in Breast Cancer: Targets and Therapy

Authors: Ishani Wickramage | Kamani Hemamala Tennekoon | Merenchi Arachchige Yasantha Ariyaratne | Sudeshini Hewage | Tharmini Sundralingam

Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis

JOURNAL ARTICLE published April 2021 in Breast Cancer: Targets and Therapy

Authors: Ami Vyas | Meghan Gabriel | Sobha Kurian

Emerging role of cell polarity proteins in breast cancer progression and metastasis

JOURNAL ARTICLE published January 2014 in Breast Cancer: Targets and Therapy

Authors: Luke McCaffrey | Sudipa Chatterjee

Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2&ndash; metastatic breast cancer

JOURNAL ARTICLE published May 2018 in Breast Cancer: Targets and Therapy

Authors: Anna Forsythe | David Chandiwana | Janina Barth | Marroon Thabane | Johan Baeck | Gabriel Tremblay

Hypofractionated whole breast radiotherapy: current perspectives

JOURNAL ARTICLE published October 2015 in Breast Cancer: Targets and Therapy

Authors: Theodora Koulis | Tien Phan | Ivo Olivotto